Physician profile
Beverly Shaw
NPI 1023548591
$630.34
in general payments reported to CMS, 2019-2025
20 companies · $17.23 in 2025
The $17.23 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.95 · 2022: $15.45 · 2023: $250 · 2024: $270 · 2025: $17.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $69.45 | 2022-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Neurocrine Biosciences, INC. | $66.92 | 2024 | Ingrezza |
| Pfizer INC. | $60.67 | 2021-2024 | |
| Novo Nordisk INC | $54.72 | 2023-2024 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.31 | 2023-2024 | Ofev, Tradjenta, Synjardy |
| Otsuka America Pharmaceutical, INC. | $44.52 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $32.15 | 2023-2024 | Cologuard Collection Kit |
| Baxter Healthcare | $30.33 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $28.43 | 2023-2024 | Farxiga, Airsupra |
| Abbvie INC. | $26.29 | 2023 | |
| Sumitomo Pharma America, INC. | $23.71 | 2023 | Gemtesa |
| Cranial Technologies, INC | $21.11 | 2024 | Doc Band |
| Pbg Puerto Rico LLC | $19.52 | 2021 | |
| Medtronic, INC. | $17.23 | 2025 | Interstim |
| Amgen INC. | $17.04 | 2024 | Otezla |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $16.28 | 2021 | |
| Lilly USA, LLC | $15.12 | 2023 | Mounjaro |
| Verrica Pharmaceuticals INC. | $14.15 | 2023 | Ycanth |
| Phadia US INC. | $14.00 | 2021 | |
| Neos Therapeutics, LP | $13.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.